Edward M. Kaye
2012 - Sarepta Therapeutics
In 2012, Edward M. Kaye earned a total compensation of $1.2M as Interim Chief Executive Officer, Senior Vice President, Chief Medical Officer at Sarepta Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,620 |
|---|---|
| Option Awards | $613,634 |
| Salary | $364,000 |
| Other | $10,685 |
| Total | $1,153,939 |
Kaye received $613.6K in option awards, accounting for 53% of the total pay in 2012.
Kaye also received $165.6K in non-equity incentive plan, $364K in salary and $10.7K in other compensation.
Rankings
In 2012, Edward M. Kaye's compensation ranked 5,574th out of 11,487 executives tracked by ExecPay. In other words, Kaye earned more than 51.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,574 out of 11,487 | 52nd |
Division Manufacturing | 1,972 out of 4,253 | 54th |
Major group Chemicals And Allied Products | 475 out of 1,198 | 60th |
Industry group Drugs | 317 out of 920 | 66th |
Industry Pharmaceutical Preparations | 248 out of 700 | 65th |
Source: SEC filing on April 30, 2015.
Kaye's colleagues
We found seven more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2012.
2012
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
David Howton
Sarepta Therapeutics
General Counsel
2012
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2012
Michael Jacobsen
Sarepta Therapeutics
Vice President, Finance
2012
Jayant Aphale
Sarepta Therapeutics
Senior Vice President, Technical Operations
2012
Effie Toshav
Sarepta Therapeutics